Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meksibel, Indometacin, Meloksicam, and Oktride for Post-ERCP Pancreatitis Prevention
NCT04608760Phase 1Unknown
- Sponsor
- Vitebsk State Medical University
- Start
- Aug 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Meksibel in acute pancreatitis (AP), sponsored by Vitebsk State Medical University. Status: unknown.
02
Drugs
Meksibel
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT04608760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04608760.